In inflammatory bowel disease, LPS or cytokines (e.g. IL-6 and IFN-γ) can activate JAK/STAT signaling pathway to regulate the expression of pro-inflammatory mediators including Claudin-2 and iNOS [29]. Here, CLDN2 is linked to inflammatory bowel disease.